Valuation: OraSure Technologies, Inc.

Market Cap 265M 229M 215M 195M 368M 25.32B 374M 2.52B 985M 12.68B 994M 973M 42.14B P/E 2026 *
-5.82x
P/E 2027 * -4.74x
Enterprise Value 265M 229M 215M 195M 368M 25.32B 374M 2.52B 985M 12.68B 994M 973M 42.14B EV / Sales 2026 *
2.17x
EV / Sales 2027 * 1.99x
Free-Float
93.63%
Yield 2026 *
-
Yield 2027 * -
1 day-4.48%
1 week-5.19%
Current month-5.19%
1 month-3.03%
3 months+28.00%
6 months+39.64%
Current year+58.68%
1 week 3.69
Extreme 3.69
4.05
1 month 3.69
Extreme 3.69
4.24
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 2022-06-03
Director of Finance/CFO 54 2022-08-07
Chief Tech/Sci/R&D Officer - 2024-11-30
Director TitleAgeSince
Director/Board Member 66 2021-11-07
Director/Board Member 52 2022-06-03
Director/Board Member 57 2023-07-30
Date Insider Type Main position Quantity % Market Cap.
3/1/26 Free

Controller/Auditor

72,044 0.1004%
3/1/26 Free

Chief Executive Officer

663,267 0.9246%
3/1/26 Free

Chief Financial Officer

143,546 0.2001%
Change 5-day change 1-year change 3-year change Capi.($)
-4.48%-5.19%+39.13%-40.37% 265M
-0.02%+3.19%-15.56%+6.43% 193B
+0.76%+4.72%-1.88%+11.89% 117B
+1.43%-2.07%+7.17%+70.56% 59.89B
-1.56%-0.08%+33.69%+69.88% 56.01B
+0.79%+3.70%-6.40%-33.73% 49.96B
-1.89%+5.90%+10.87%-19.26% 33.87B
+0.45%+1.45% - - 31.36B
-1.83%+1.86%-5.92%+27.73% 24.77B
+0.94%-1.31%+41.93%-12.09% 24.59B
Average -0.54%+2.80%+11.45%+9.00% 59B
Weighted average by Cap. +0.08%+3.40%+0.08%+15.77%

Financials

2026 *2027 *
Net sales 122M 105M 99.1M 90.13M 169M 11.68B 172M 1.16B 454M 5.85B 458M 449M 19.43B 133M 115M 108M 98.32M 185M 12.74B 188M 1.27B 495M 6.38B 500M 489M 21.2B
Net income -46.2M -39.9M -37.49M -34.1M -64.11M -4.42B -65.17M -439M -172M -2.21B -173M -170M -7.35B -57.65M -49.8M -46.79M -42.56M -80.01M -5.51B -81.33M -548M -214M -2.76B -216M -212M -9.17B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26-08-14 US$3.840 -4.48% 582,448
26-08-13 US$4.020 +7.20% 708,461
26-08-12 US$3.750 -3.35% 619,547
26-08-11 US$3.880 -3.00% 310,571
26-08-10 US$4.000 -1.23% 404,565
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.840USD
Average target price
4.000USD
Spread / Average Target
+4.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock